Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Elevation Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ELEV.
You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.
Other companies in Elevation Oncology’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Nanoviricides (AMEX:NNVC), GlycoMimetics (NASDAQ:GLYC), Portage Biotech (NASDAQ:PRTG) and ABVC BioPharma (NASDAQ:ABVC).
Elevation Oncology has a consensus price target of $4.22.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $0.34 last updated May 2, 2025 at 5:41 PM EDT.
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology’s Q1 earnings are confirmed for Friday, May 16, 2025.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.